Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

News feed

Yandex has completed the training of Alice AI to help in the selection of products

1/14/26 YDEX

Shareholders of Zaymer approved the change of status to MKK

1/14/26 ZAYM

Astra is negotiating the purchase of a controlling stake in the developer of MyOffice

1/14/26 ASTR

Ozon launches its own beauty brand of care cosmetics

1/14/26 OZON

Glorax sales in 2025 increased by 80%

1/14/26 GLRX

Major shareholders of Positive Technologies have agreed on a long-term lock-up

1/13/26 POSI

Vladislav Bakalchuk will join the Board of Directors of VseInstruments.ru

1/13/26 VSEH

Lambumiz may have a strategic investor from China

1/13/26 LMBZ

Shareholders of European Eltech approved dividends

1/13/26 EELT

Inter RAO has made an offer to the minority shareholders of Saratovenergo

1/13/26 SARE